Stasys Medical Corporation
KIRKLAND, WA · Founded 2012 · CIK 0001632952 · Medtech · Private
Atlas PST, an automated platelet function testing device using shear force to measure platelet activation without external reagents
stasysmedical.com →- Grants
- $1.2M
- 2 awards
- Sector median: 1
- Raised
- $1.4M
- 2 Form D · Jun 2017
- 112 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2014201520162017201820192020
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $160,466 | |
| Federal grant | National Science Foundation · Phase II · SBIR Phase II: Development of a rapid assay for the personalized assessment of clot dysfunction due to trauma | $1,010,229 | |
| Private capital raised | Form D · SEC | $1,253,107 | |
| Federal grant | Department of Health and Human Services · Phase I · Stasys Medical: A Rapid, Microfluidic Blood Test Sensitive to Platelet Dysfunction | $224,945 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1379 | CROOKES RESEARCH LLC | — | — |
| 1380 | RESOLV TECHNOLOGY INC | — | $5.7M |
| 1381 | OPAL HTM INC | — | — |
| 1382 | Stasys Medical Corporation | — | $1.4M |
| 1383 | Sintact Medical Systems, LLC | — | $104K |
| 1384 | Suneva Medical, Inc. | — | $137M |
| 1385 | Rational Vaccines, Inc. | — | $18M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Robert BarryDirector · Executive Officer · Promoter
- Mark DyeDirector
- Chris IgielskiDirector
- Michael RackleyDirector · Executive Officer
- Linden RhoadsDirector
- Nathan SniadeckiDirector · Promoter
- Nathan WhiteDirector · Promoter
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.